Home » Health Care & Life Sciences

Health Care & Life Sciences

Articles

Hospitals are mixed bag for rural economies

Around Indiana, hospitals continue to grow and add workers, increasing their role as an economic driver to the state’s economy.
But health care reformers say hospital growth has a double edge, as higher health care costs dampen growth prospects for other
Indiana employers and their workers.

Read More

Health network leading charge for electronic patient records

Four years after its launch, the Indiana Health Information Exchange is laying the groundwork to take its game outside state
borders. The Indianapolis-based not-for-profit offers a service that provides patient records and test results via computer
to hospitals and doctors around central Indiana. But now, its leaders think they can take their expertise to other cities
and help them develop their own health information exchanges.

Read More

Startup NICO Corp. hopes to commercialize brain surgery device

Economists call it a “virtuous cycle” when successful entrepreneurs plow their gains into new businesses. Jim Pearson calls
it another day on the job. The former Suros Surgical Systems Inc. CEO is attempting to repeat what he already has done: Build
a company to bring a promising medical device all the way from the drawing board to the market.

Read More

Janitors want Lilly, WellPoint to push for better health benefits

Service Employees International Union Local 3 is backing local janitors as they restart contract negotiations April 16 with
five of the largest janitorial contractors in Indianapolis. SEIU now is taking direct aim at Lilly, health insurer WellPoint
Inc. and even some local hospitals, hoping they will pressure the janitorial contractors to come to terms.

Read More

Anthem increases its hold on Indiana

Anthem Insurance Co. added nearly 75,000 commercial customers last year, pushing its total up more than 4 percent. Anthem,
a subsidiary of Indianapolis-based WellPoint Inc., now claims a whopping 1.8 million commercial customers in the state. The
trouble is, Anthem’s dominance limits price competition, according to benefits brokers, making it hard for local HMOs such
as M-Plan or even some national players to compete.

Read More

Lilly expects FDA approval of long-acting version of Zyprexa

Eli Lilly and Co. hopes to extend the life of its best-seller Zyprexa with a potentially lucrative, long-acting form of the antipsychotic drug. But first, the Indianapolis-based drugmaker must win over a panel of medical experts convened by the U.S. Food and Drug Administration on Feb. 6.

Read More

Braly gains prestige–fast

At the beginning of 2007, few people outside WellPoint Inc. had even heard of Angela Braly. Nine months later, Fortune magazine
named her the fourth most powerful woman in business.

Read More

Taurel passes the baton

A new leader will guide the city’s largest company in 2008, with some of the biggest challenges in its history on the horizon.
Eli Lilly and Co. announced Dec. 18 that CEO Sidney Taurel will step down March 31 and will be replaced by President John
C. Lechleiter, who has been the heir apparent for more than two years.

Read More

New Lilly CEO called analytical, ‘incredibly warm’

John C. Lechleiter, whom Eli Lilly and Co.’s board voted to replace Sidney Taurel as CEO, is known for getting things done
and yet also for being good at analysis and relating to people under him. Taurel will step down at the end of March but remain
chairman until the end of 2008.

Read More

Lilly’s plan to outsource more work is good news, bad news

Eli Lilly and Co. will shrink itself with “great intensity” over the next few years, in part by
outsourcing. For other local life sciences firms, that’s a fat pitch for new business. But it’s not clear if non-Lilly firms
can grow fast enough to offset the jobs and wages Indianapolis will lose from Lilly.

Read More

Clarian hospitals in Avon, Carmel turn corner after big losses

Clarian Health officials say the only way they can keep operating their medical centers downtown is to support them with profitable
suburban hospitals. So far, it seems Clarian is on the right track. As Clarian moves forward with a new, $180 million hospital
in Fishers, its two existing suburban hospitals are starting to make money.

Read More

Lilly under gun to replace aging blockbuster Zyprexa

There’s a $2 billion hole in Eli Lilly and Co.’s future. That’s roughly how much pretax profit Lilly derives each year from
its best-seller, Zyprexa, according to calculations by IBJ. And it’s how much black ink will start running off Lilly’s books
once Zyprexa’s U.S. and European patents expire in 2011.

Read More

Angie’s List CEO wanted shot at WellPoint’s Zagat deal

WellPoint Inc. and Angie’s List are both racing to launch doctor-rating services early next year. But Angie’s List is already
sour over Well-Point’s decision to partner with New York-based Zagat Survey LLC for its doctor-rating service, apparently
without talking to Angie’s List.

Read More

WellPoint adjusts to executive exodus

Fifteen senior executives have left WellPoint Inc. since November 2004, when the giant health insurer formed through Indianapolis-based
Anthem Inc.’s $16.5 billion acquisition of California-based WellPoint Health Networks Inc. The merger made many of them rich,
work at WellPoint was grueling, and personal commitments called. So they moved on.

Read More